Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Broker tips: MP Evans, Essentra

(Sharecast News) - Analysts at Canaccord Genuity raised their target price on palm oil business MP Evans from 1,350.0p to 1,400.0p on Tuesday, stating the group was "continuing on the right path". Canaccord Genuity said MP Evans's recent trading update highlighted a strong operational and financial performance in 2024 despite moderately challenging weather conditions in certain Indonesian regions due to dry weather.

The Canadian bank said MP Evans' total processed crop remained broadly stable compared to 2023, reaching approximately 1.61m tonnes, driven by increased production of own crops and smallholder scheme crops.

However, purchases from independent suppliers were lower than expectations due to robust internal production.

"We continue to view the company as well-positioned to deliver strong results. With consistent performance and unchanged conditions," said Canaccord Genuity.

Analysts at Berenberg lowered their target price on essential components manufacturer Essentra from 200.0p to 170.0p on Tuesday, stating it had tempered its outlook for the group's FY25 trading performance.

Essentra said trading conditions in Q4 continued to be mixed for the group, with EMEA region revenues softening further, trading in the Americas stabilising, and Asia-Pacific delivering a steady improvement.

Berenberg stated that on account of expected continued revenue declines in the EMEA region, it thinks it prudent to expect a flat sales performance in FY25 at the group level.

Further, due to differing regional profitability profiles, the German bank's updated regional mix assumptions lead it to downwardly revise its FY25 group underlying earnings forecasts from roughly £45.0m to approximately £36.0m - a 20% downgrade.

"While disappointing, we expect this now marks trough-earnings for the group, on a trough multiple (15.2x FY 2025 P/E, or 12.5x FY 2026 before any share price movement) and we continue to view Essentra as well placed to benefit when markets (particularly in Europe) eventually normalise," said Berenberg, which reiterated its 'buy' rating on the stock.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Europe midday: Shares pare losses as investors digest China tariff move
(Sharecast News) - European stocks pared losses as investors digested China's retaliatory moves against US tariffs and the 30-day pause on levies against Canada and Mexico.
US pre-open: Futures slightly lower as tariff headlines remain in focus
(Sharecast News) - Wall Street futures were in the red ahead of the bell on Tuesday as the effects of the new White House administration's tariffs on a number of its closest trading partners continued to be seen.
Asia report: Markets bounce back from Trump tariff sell-off
(Sharecast News) - Asia-Pacific markets advanced on Tuesday as investor sentiment improved following Donald Trump's decision to pause tariffs on Mexico and Canada for a month.
London open: FTSE falls again as China retaliates against US
(Sharecast News) - London stocks were lower again in early trade on Tuesday following heavy losses a day earlier, after China announced retaliatory tariffs on a range of US imports.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.